In-Vivo CAR-T Cell Therapy: The Next Chapter in Oncology
Cell Therapy: Cancer’s New Arsenal Though several therapeutic, biotech, and medtech developments are changing the oncology landscape, in-vivo CAR-T cell therapy stands out for its precision, accessibility, and upscaling capabilities. A step up from ex vivo CAR-T cell therapy, it takes precedence due to its improved toxicity management, manufacturing parameters, and broader scope of clinical […]
In-vivo CAR-T Cell Therapy: New Frontier in Cancer Treatment
Chimeric antigen receptor T-cell (CAR-T) therapy transformed oncology by paving the path for harnessing patients’ own cells to treat B-cell lymphomas, leukemias, and other hematological malignancies. Traditionally, CAR-T cell therapy for cancer relied on ex vivo processes, where a patient’s T-cells are extracted, genetically reprogrammed in an external medium to express synthetic receptors targeting cancer […]
Therapeutic Potential of Epigenetic Reprogramming
Epigenetics refers to the stable modifications in cell functioning that result from environmental and behavioral factors, which do not involve changes in the DNA sequence. Epigenetic reprogramming methods, which have undergone significant advancements, are currently at the forefront of medical research and are gaining widespread attention as promising strategies for treating various disorders/diseases. The technology entails epigenome remodeling. It results […]